TREM1 and hepatocellular carcinoma: Flow cytometry analysis revealed that a significant proportion (80 ± 6%) of CD133+EpCAM+ LCSLCs in Huh7 and HepG2 cell lines and the primary HCC P1 patient sample actively expressed TREM1 (Figure 3A).